A recombinant replication competent retrovirus for gene deliver and gene therapy
is provided. The recombinant retrovirus has a heterologous nucleic acid sequence,
a sequence encoding a cell- or tissue-specific ligand or a sequence for transcriptional
targeting, or a combination of both a cell- or tissue-specific ligand and a cell-
or tissue-specific transcriptional targeting sequence.